![]() Postmarketing reports: Cellulitis Dermatologic Postmarketing reports: Allergic reactions including anaphylactic shock, serum sickness, and death Stevens-Johnson syndrome ImmunologicĬommon (1% to 10%): Infection, influenza-like illness Postmarketing reports: Insomnia Hypersensitivity Very common (10% or more): Irritability (54%) Very common (10% or more): Loss of appetite (33.3%), decreased appetite (21%) Psychiatric Postmarketing reports: Dysphagia, abdominal pain, swelling of the mouth, throat, and/or tongue Metabolic Postmarketing reports: Rhinitis, laryngitis, dyspnea, dysphonia, bronchospasm, throat tightness, pharyngitis, epistaxis Gastrointestinal Very common (10% or more): Runny nose/nasal congestion (58%), cough (15%), upper respiratory tract infection (13%)Ĭommon (1% to 10%): Sore throat, cough, oropharyngeal pain, rhinorrhea, wheezing, pharyngolaryngeal pain, nasopharyngitis Postmarketing reports: Neuralgia, paresthesia, convulsions (including febrile seizures), encephalopathy, neuritis or neuropathy, transverse myelitis, Guillain-Barre syndrome, abnormal gait, dizziness, hypoesthesia, hypokinesia, tremor, somnolence, syncope, facial or cranial nerve paralysis, encephalopathy, limb paralysis, confusion, paralysis (including Bell's Palsy), vertigo, exacerbation of symptoms of mitochondrial encephalomyopathy (Leigh syndrome), meningitis, eosinophilic meningitis, vaccine-associated encephalitis Respiratory Postmarketing reports: Muscle weakness, arthritis, arthralgia, myasthenia Nervous system Postmarketing reports: Hot flashes/flushes MusculoskeletalĬommon (1% to 10%): Chills/shivering, back pain Postmarketing reports: Cellulitis, injection site inflammation, injection site sterile abscess Other The most common adverse events were local reactions, myalgia, and headache.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |